Abstract
To find out what role, if any,β 2-adrenoceptors play in cardiac contractility, the heart rate, stroke volume and cardiac output of twelve healthy male and female volunteers (aged 18–28 years) were studied at rest (standing) and during two stages of treadmill exercise, 2 h after ingestion of propranolol (100 mg) or atenolol (100 mg) or a placebo, on different occasions, in a double-blind crossover manner. Cardiac output was measured by a carbon dioxide—rebreathing method. Atenolol and propranolol caused equal reductions in heart rate at rest, and in heart rate and cardiac output during exercise (p < 0.001, two-way analysis of variance). Neither atenolol nor propranolol had any significant effect on resting cardiac output, resting stroke volume or stroke volume during exercise. Since atenolol (100 mg) has been shown to beβ 1-adrenoceptorselective, we conclude that cardiac inotropic function during exercise is largelyβ 1-adrenoceptor-mediated with little or noβ 2-adrenoceptor involvement.
Similar content being viewed by others
References
Brodde OE. Cardiac beta-adrenoceptors.ISI Atlas Sci Pharmacol 1987;1: 107–112.
Brodde OE.β 1- andβ 2-adrenoceptors in the human heart: properties, function, and alteration in chronic heart failure.Pharmacol Rev 1991;43: 203–242.
Kaumann AJ. Is there a third heartβ-adrenoceptor?Trends Pharmacol Sci 1989;10: 316–320.
Zaagsma J, Nahorski SR. Is the adipocyteβ-adrenoceptor a prototype for the recently cloned atypicalβ 3-adrenoceptor?Trends Pharmacol Sci 1990;125: 3–7.
Waller DG.β-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?Br J Clin Pharmacol 1990;30: 157–171.
Fujimura A, Kumagai Y, Sugimoto K, Nakashima H, Kajiyama H, Ebihara A, Ohashi K. Circadian influence on effect of propranolol on exercise induced tachycardia in healthy subjects.Eur J Clin Pharmacol 1990;38: 133–137.
Collier CR. Determination of mixed venous tentions by rebreathing.J Appl Physiol 1956;9: 25–29.
Ashton CH, McHardy GJR. A rebreathing method for determining mixed venous Pco2 during exercise.J Appl Physiol 1963;18: 668–671.
Denison D. Mixed venous blood gas tensions and respiratory stress in man. PhD Thesis, Univ London, 1968.
Zeidifard E, Silverman M, Godfrey S. Reproducibility of the indirect (CO2) Fick method for calculation of cardiac output.J Appl Physiol 1972;33: 141–143.
Jones NL, Rebuck AS. Rebreathing of CO2 during exercise.J Appl Physiol 1973;35: 538–541.
Muiesan G, Sorbini CA, Solinas E, Grassi V, Casucci G, Petz E. Comparison of CO2 rebreathing and direct Fick methods for determining cardiac output.J Appl Physiol 1968;24: 424–429.
Reybrouck T, Amery A, Billiet L, Fagard R, Stijns H. Comparison of cardiac output determination by a carbon dioxide rebreathing and direct Fick method at rest and during exercise.Clin Sci Mol Med 1978;55: 445–452.
Hamilton WF. The Lewis A. Connor memorial lecture. The physiology of cardiac output.Circulation 1953;8: 527–543.
Robinson S, Pearcy M, Brueckman FR, Nicholas JR, Miller D. Effects of atropine on heart rate and oxygen intake in working man.J Appl Physiol 1953;5: 508–512.
Robinson BF, Epstein SE, Beiser CD, Braunwald E. Control of heart rate by the autonomic nervous system. Studies in man on the inter-relation between baroreceptor mechanisms and exercise.Circ Res 1966;19: 400–411.
Christensen NJ, Galbo H, Hansen JF, Hesse B, Richtert EA, Trap-Jensen J. Catecholamines and exercise.Diabetes 1979;28(S1): 58–62.
Price HL. Circulating adrenaline and noradrenaline during diethylether anaesthesia.Clin Sci 1957;16: 377–387.
Robertson D, Garland A, Johnson GA, Robertson RM, Nies AS, Shand D, Oakes JA. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.Circulation 1979;59: 637–643.
Friedman DB, Ordway GA, Williams RS. Exercise-induced functional desensitization of canine cardiacβ-adrenoceptors.J Appl Physiol 1987;62: 1721–1723.
Fitzgerald JD, Gumbrielle T, Harry JD. Effects in man of ICI 118551 (A selectiveβ 2-adrenoceptor blocking drug) on some cardiovascular responses induced by isoprenaline.Br J Clin Pharmacol 1981;13: 586P.
Hespel P, Lijnen P, Vanhees L, Fagard R, Amery A. Betaadrenoceptors and the regulation of BP and plasma renin during exercise.J Appl Physiol 1986;60: 108–113.
Jefferson D, Wharrad HJ, Birmingham AT, Patrick JM. The comparative effects of ICI 118551 and propranolol on essential tremor.Br J Clin Pharmacol 1987;24: 729–734.
Pringle TH, Riddell JG, Shanks RG. Characterization of the beta-adrenoceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.Eur J Clin Pharmacol 1988;35: 507–514.
Cleeves L, Findley LJ. Beta-adrenoceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoceptor antagonist.J Neurol Neurosurg Psychiatry 1984;47: 976–982.
Strauss MH, Reeves RA, Smith DL, Leenen FHH. The role of the cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist.Clin Pharmacol Ther 1986;40: 108–115.
Leenen FHH, Chan YK, Smith DL, Reeves RA. Epinephrine and left ventricular function in humans: effects of beta-1 vs nonselective beta-blockade.Clin Pharmacol Ther 1988;43: 519–528.
Brodde OE, Daul A, Wellstein A, Palm D, Michel MC, Beckeringh JJ. Differentiation of beta-1- and beta-2-adrenoceptor-mediated effects in humans.Am J Physiol 1988;254: H199-H206.
Motomura S, Zerkowski HR, Daul A, Brodde OE. On the physiologic role of beta-2 adrenoceptors in the human heart:in vitro andin vivo studies.Am Heart J 1990;119: 608–619.
Conway FJ, Fitzgerald JD, McAinsh J, Rowlands DJ, Simpson WT. Human pharmacokinetic and pharmacodynamic studies on atenolol (ICI 66,082), a new cardioselectiveβ-adrenoceptor blocking drug.Br J Clin Pharmacol 1976;3: 267–272.
De Plaen JF, Amery A, Reybrouck T. Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.Eur J Clin Pharmacol 1976;10: 297–303.
Gugler R, Krist R, Raczinski H, Hoffgen K, Bodem G. Comparative pharmacodynamics and plasma levels ofβ-adrenoceptor blocking drugs.Br J Clin Pharmacol 1980;10: 337–343.
Brown JE, McLeod AA, Shand DG. Evidence for cardiacβ 2-adrenoceptors in man.Clin Pharmacol Ther 1983;33: 424–428.
Brown JE, McLeod AA, Shand DG. In support of cardiac chronotropic beta2-adrenoceptors.Am J Cardiol 1986;57: 11F-16F.
Tattersfield AE, Cragg DJ. Effect of ICI 118,551 on bronchialβ-adrenoceptor function and exercise heart rate in normal man.Br J Clin Pharmacol 1983;16: 587–590.
Arnold JMO, O'Connor PC, Riddell JG, Harron DWG, Shanks RG, McDevitt DG. Effectsβ 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-inducedβ-adrenoceptor responses in man.Br J Clin Pharmacol 1985;19: 619–630.
Leenen FHH, Coenen CHM, Zonderland M, Maas AHJ. Effects of cardioselective and non-cardioselective beta-blockade on dynamic exercise performance in mildly hypertensive men.Clin Pharmacol Ther 1990;28: 12–21.
Benson MK, Berrill WT, Decalmer PB, Sterling GM, Chatterjee SS, Croxson RS, Cruickshank JM. Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease.Postgrad Med J 1977;53: 143S-148S.
Decalmer PBS, Chatterjee SS, Cruickshank JM, Benson MK, Sterling GM. Beta-blockers and asthma.Br Heart J 1978;40: 184–189.
Ellis ME, Sahay JN, Chatterjee SS, Cruickshank JM, Ellis SH. Cardioselectivity of atenolol in asthmatic patients.Eur J Clin Pharmacol 1981;21: 173–176.
Rahman MA, Bennett T. The effects of propranolol or atenolol on the cardiovascular responses to central hypovolaemia in Europeans and Bengalees.Br J Clin Pharmacol 1990;29: 69–77.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nyarko-Adomfeh, C. Cardiacβ 2-adrenoceptors and the inotropic response to exercise in man. Clinical Autonomic Research 1, 317–321 (1991). https://doi.org/10.1007/BF01819838
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01819838